DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Perez EA, Barrios C, Eiermann W, Toi M, Im YH, Conte P. et al.
Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: Primary results from the phase III MARIANNE study.
J Clin Oncol 2017;
35: 141-8
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.